Jpmorgan Chase & Co »

Blueprint Medicines Corp cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Blueprint Medicines Corp cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Blueprint Medicines Corp cmn

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines Corp cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines Corp cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 400 92.50
2024-06-30 $65k 600 107.78
2024-03-31 $152k 1.6k 94.86
2020-03-31 $175k 3.0k 58.33
2019-12-31 $240k 3.0k 80.00
2019-06-30 $6.5M 70k 92.71
2018-09-30 $2.3M 30k 78.07
2018-06-30 $1.9M 30k 63.47
2018-03-31 $2.5M 27k 91.70

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Blueprint Medicines Corp cmn

Group One Trading
Simplex Trading
Jpmorgan Chase & Co

View all funds holding Blueprint Medicines Corp cmn